Jack Lennon, president of UV Flu Technologies said: “We believe the European marketplace offers exceptional opportunities for us," said Mr. Lennon. "Europe has had incredible problems with MRSA, and other HAI's, or Hospital Associated Infections, which are bacterial strains that have grown impervious to antibiotics. In Wales recently, an outbreak of Legionnaires Disease brought the problem of poor air quality back as front page news. This disease is still widespread around the world, but experts believe it is usually misdiagnosed as pneumonia. The ViraTech UV-400 kills many of these types of airborne contaminants thereby minimizing their ability to spread, so we believe we can easily help reverse the possibility of dramatic increases in some of the most common, yet potentially deadly situations.”
